| # | Drug | Count |
|---|---|---|
| 0 | EMPAGLIFLOZIN | 168 |
| 1 | METFORMIN | 162 |
| 2 | ALEMTUZUMAB | 157 |
| 3 | ACETAMINOPHEN | 142 |
| 4 | METHYLPREDNISOLONE | 142 |
| 5 | DAPAGLIFLOZIN | 136 |
| 6 | DIPHENHYDRAMINE HYDROCHLORIDE | 121 |
| 7 | METFORMIN ER 500 MG | 119 |
| 8 | METFORMIN ER 750 MG | 119 |
| 9 | DIMENHYDRINATE | 93 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERTUGLIFLOZIN | 18 | 0.0161 |
| 1 | DIMENHYDRINATE | 93 | 0.0087 |
| 2 | ALEMTUZUMAB | 157 | 0.0081 |
| 3 | CIMETIDINE | 43 | 0.0045 |
| 4 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 11 | 0.0031 |
| 5 | ERGOCALCIFEROL | 91 | 0.0031 |
| 6 | CANAGLIFLOZIN | 77 | 0.0026 |
| 7 | ACARBOSE | 10 | 0.0025 |
| 8 | EMPAGLIFLOZIN | 168 | 0.0024 |
| 9 | GLUCAGON | 10 | 0.0024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 290 |
| 1 | Insulin Analog [EPC] | 221 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 221 |
| 3 | Corticosteroid [EPC] | 186 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 157 |
| 5 | Benzodiazepine [EPC] | 99 |
| 6 | Provitamin D2 Compound [EPC] | 91 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 86 |
| 8 | Atypical Antipsychotic [EPC] | 82 |
| 9 | Proton Pump Inhibitor [EPC] | 78 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 157 | 0.0081 |
| 1 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 3 | 0.0040 |
| 2 | Provitamin D2 Compound [EPC] | 91 | 0.0031 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 290 | 0.0027 |
| 4 | Antihypoglycemic Agent [EPC] | 10 | 0.0023 |
| 5 | alpha-Glucosidase Inhibitor [EPC] | 11 | 0.0023 |
| 6 | Reducing and Complexing Thiol [EPC] | 4 | 0.0016 |
| 7 | Glinide [EPC] | 10 | 0.0011 |
| 8 | Antifibrinolytic Agent [EPC] | 11 | 0.0011 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |